Infirst gains Mylanta and Mylicon rights in US

4 March 2015 - Deborah Wilkes


Infirst Healthcare has gained the rights to market Johnson & Johnson's Mylanta and Mylicon ranges of gastrointestinal remedies in the US.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: